507 related articles for article (PubMed ID: 12960934)
1. The use of proton MRS in the differential diagnosis of brain tumors and tumor-like processes.
Gajewicz W; Papierz W; Szymczak W; Goraj B
Med Sci Monit; 2003 Sep; 9(9):MT97-105. PubMed ID: 12960934
[TBL] [Abstract][Full Text] [Related]
2. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
[TBL] [Abstract][Full Text] [Related]
3. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions.
Lai PH; Hsu SS; Ding SW; Ko CW; Fu JH; Weng MJ; Yeh LR; Wu MT; Liang HL; Chen CK; Pan HB
Surg Neurol; 2007; 68 Suppl 1():S25-36. PubMed ID: 17963918
[TBL] [Abstract][Full Text] [Related]
4. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
5. Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens.
Cheng LL; Chang IW; Louis DN; Gonzalez RG
Cancer Res; 1998 May; 58(9):1825-32. PubMed ID: 9581820
[TBL] [Abstract][Full Text] [Related]
6. Role of proton magnetic resonance spectroscopy in differentiating oligodendrogliomas from astrocytomas.
Chawla S; Oleaga L; Wang S; Krejza J; Wolf RL; Woo JH; O'Rourke DM; Judy KD; Grady MS; Melhem ER; Poptani H
J Neuroimaging; 2010 Jan; 20(1):3-8. PubMed ID: 19021846
[TBL] [Abstract][Full Text] [Related]
7. [1H-MR Spectroscopy of brain tumors in the course of radiation therapy: Use of fast spectroscopic imaging and single-voxel spectroscopy for diagnosing recurrence].
Träber F; Block W; Flacke S; Lamerichs R; Schüller H; Urbach H; Keller E; Schild HH
Rofo; 2002 Jan; 174(1):33-42. PubMed ID: 11793282
[TBL] [Abstract][Full Text] [Related]
8. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
[TBL] [Abstract][Full Text] [Related]
9. Role of in vivo proton MR spectroscopy in the evaluation of adult brain lesions: our preliminary experience.
Kumar A; Kaushik S; Tripathi RP; Kaur P; Khushu S
Neurol India; 2003 Dec; 51(4):474-8. PubMed ID: 14742925
[TBL] [Abstract][Full Text] [Related]
10. MRS of oligodendroglial tumors: correlation with histopathology and genetic subtypes.
Jenkinson MD; Smith TS; Joyce K; Fildes D; du Plessis DG; Warnke PC; Walker C
Neurology; 2005 Jun; 64(12):2085-9. PubMed ID: 15985578
[TBL] [Abstract][Full Text] [Related]
11. [Magnetic resonance in the study of cerebral gliomas].
Vaghi MA; Visciani A; Passerini A; Longone V; Broggi G
Radiol Med; 1986 Jun; 72(6):431-8. PubMed ID: 3012662
[TBL] [Abstract][Full Text] [Related]
12. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.
Stadlbauer A; Moser E; Gruber S; Buslei R; Nimsky C; Fahlbusch R; Ganslandt O
Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395
[TBL] [Abstract][Full Text] [Related]
13. Can the apparent diffusion coefficient be used as a noninvasive parameter to distinguish tumor tissue from peritumoral tissue in cerebral gliomas?
Pauleit D; Langen KJ; Floeth F; Hautzel H; Riemenschneider MJ; Reifenberger G; Shah NJ; Müller HW
J Magn Reson Imaging; 2004 Nov; 20(5):758-64. PubMed ID: 15503327
[TBL] [Abstract][Full Text] [Related]
14. Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas.
Demir MK; Iplikcioglu AC; Dincer A; Arslan M; Sav A
Eur J Radiol; 2006 Oct; 60(1):48-55. PubMed ID: 16844335
[TBL] [Abstract][Full Text] [Related]
15. [Diffusion-weighted MRI in the differentiation of brain abscesses and necrotic tumors].
Hakyemez B; Ergin N; Uysal S; Işik I; Kiliç E
Tani Girisim Radyol; 2004 Jun; 10(2):110-8. PubMed ID: 15236124
[TBL] [Abstract][Full Text] [Related]
16. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
[TBL] [Abstract][Full Text] [Related]
17. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
18. In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging.
De Stefano N; Caramanos Z; Preul MC; Francis G; Antel JP; Arnold DL
Ann Neurol; 1998 Aug; 44(2):273-8. PubMed ID: 9708554
[TBL] [Abstract][Full Text] [Related]
19. Association of 99mTc-MIBI brain SPECT and proton magnetic resonance spectroscopy (1H-MRS) to assess glioma recurrence after radiotherapy.
Palumbo B; Lupattelli M; Pelliccioli GP; Chiarini P; Moschini TO; Palumbo I; Siepi D; Buoncristiani P; Nardi M; Giovenali P; Palumbo R
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):88-93. PubMed ID: 16557208
[TBL] [Abstract][Full Text] [Related]
20. The effect of combining two echo times in automatic brain tumor classification by MRS.
García-Gómez JM; Tortajada S; Vidal C; Julià-Sapé M; Luts J; Moreno-Torres A; Van Huffel S; Arús C; Robles M
NMR Biomed; 2008 Nov; 21(10):1112-25. PubMed ID: 18759382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]